These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24910236)

  • 1. Fungal mediated generation of mammalian metabolites of fenofibrate and enhanced pharmacological activity of the main metabolite fenofibric acid.
    Prasad GS; Govardhan P; Girisham S; Reddy SM
    Drug Metab Lett; 2014; 8(2):88-95. PubMed ID: 24910236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate metabolism in the cynomolgus monkey using ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabolomics.
    Liu A; Patterson AD; Yang Z; Zhang X; Liu W; Qiu F; Sun H; Krausz KW; Idle JR; Gonzalez FJ; Dai R
    Drug Metab Dispos; 2009 Jun; 37(6):1157-63. PubMed ID: 19251819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New metabolites of fenofibrate in Sprague-Dawley rats by UPLC-ESI-QTOF-MS-based metabolomics coupled with LC-MS/MS.
    Liu A; Chen Y; Yang Z; Feng Y; Rui W; Luo W; Liu Y; Gonzalez FJ; Dai R
    Xenobiotica; 2009 Apr; 39(4):345-54. PubMed ID: 19350456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory activity of anti-hyperlipidemic drug, fenofibrate, and its phase-I metabolite fenofibric acid: in silico, in vitro, and in vivo studies.
    Prasad GS; Govardhan P; Deepika G; Vakdevi V; Sashidhar RB
    Inflammopharmacology; 2018 Aug; 26(4):973-981. PubMed ID: 29238904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of fenofibrate in beagle dogs: new metabolites identified and metabolic pathways revealed.
    Yang J; Luo W; Chen L; Dai R; Liu A
    Pharmazie; 2013 Jun; 68(6):414-20. PubMed ID: 23875247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biochemical pharmacology of fenofibrate.
    Caldwell J
    Cardiology; 1989; 76 Suppl 1():33-41; discussion 41-4. PubMed ID: 2713875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute oral bioavailability of fenofibric acid and choline fenofibrate in rats determined by ultra-performance liquid chromatography tandem mass spectrometry.
    Wei X; Li P; Liu M; Du Y; Wang M; Zhang J; Wang J; Liu H; Liu X
    Biomed Chromatogr; 2017 Apr; 31(4):. PubMed ID: 27594083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on microbial transformation of meloxicam by fungi.
    G SP; Girisham S; Reddy SM
    J Microbiol Biotechnol; 2009 Sep; 19(9):922-31. PubMed ID: 19809249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic inhibition of meloxicam by specific CYP2C9 inhibitors in Cunninghamella blakesleeana NCIM 687: in silico and in vitro studies.
    Prasad GS; Srisailam K; Sashidhar RB
    Springerplus; 2016; 5():166. PubMed ID: 27026863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of fenofibric acid in lipoprotein fractions of patients.
    Nobilis M; Kvetina J; Anzenbacher P; Vontor T; Svoboda D; Brátová M; Solichová D; Zadák Z; Bláha V; Vlcek J
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):287-94. PubMed ID: 9725495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate: metabolism and species differences for peroxisome proliferation in cultured hepatocytes.
    Cornu-Chagnon MC; Dupont H; Edgar A
    Fundam Appl Toxicol; 1995 Jun; 26(1):63-74. PubMed ID: 7657063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label, randomized, three-way crossover trial of the effects of coadministration of rosuvastatin and fenofibrate on the pharmacokinetic properties of rosuvastatin and fenofibric acid in healthy male volunteers.
    Martin PD; Dane AL; Schneck DW; Warwick MJ
    Clin Ther; 2003 Feb; 25(2):459-71. PubMed ID: 12749507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a sensitive liquid chromatography/tandem mass spectrometry method for the determination of fenofibric acid in rat plasma.
    Wang G; Guo J; Meng F; Song X; Zhong B; Zhao Y
    Biomed Chromatogr; 2012 Apr; 26(4):497-501. PubMed ID: 21882209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of magnesium carbonate on the solubility, dissolution and oral bioavailability of fenofibric acid powder as an alkalising solubilizer.
    Kim KS; Kim JH; Jin SG; Kim DW; Kim DS; Kim JO; Yong CS; Cho KH; Li DX; Woo JS; Choi HG
    Arch Pharm Res; 2016 Apr; 39(4):531-538. PubMed ID: 26992922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of Fenofibric Acid in Rat Plasma and its Application to a Comparative Pharmacokinetic Study of JW322 and Fenofibrate.
    Kim TK
    Drug Res (Stuttg); 2017 Sep; 67(9):534-538. PubMed ID: 28561239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between plasma fenofibric acid levels and the effect of micronized fenofibrate on cholesterol, low-density-lipoprotein cholesterol and apolipoprotein B in patients with primary hypercholesterolemia.
    Raslová K; Dubovská D; Mongiellová V; Trnovec T
    Eur J Clin Pharmacol; 1997; 52(2):101-6. PubMed ID: 9174678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotransformation of indomethacin by the fungus Cunninghamella blakesleeana.
    Zhang P; Lin LH; Huang HH; Xu HY; Zhong DF
    Acta Pharmacol Sin; 2006 Aug; 27(8):1097-102. PubMed ID: 16867265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-performance liquid chromatographic method for the determination of fenofibric acid and reduced fenofibric acid in human blood, plasma and urine].
    Abe S; Ono K; Mogi M; Hayashi T
    Yakugaku Zasshi; 1998 Oct; 118(10):447-55. PubMed ID: 9800517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of pantoprazole by the fungus Cunninghamella blakesleeana.
    Xie ZY; Huang HH; Zhong DF
    Xenobiotica; 2005 May; 35(5):467-77. PubMed ID: 16012078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary glucuronide excretion of fenofibric and clofibric acid glucuronides in man. Is it polymorphic?
    Liu HF; Vincent-Viry M; Galteau MM; Guéguen R; Magdalou J; Nicolas A; Leroy P; Siest G
    Eur J Clin Pharmacol; 1991; 41(2):153-9. PubMed ID: 1743248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.